Learn about Diabetes Mellitus with Gastroparesis, also known as Diabetic Gastroparesis. This resource provides information on diagnosis, clinical documentation, and medical coding for Gastroparesis in Diabetes. Find details on healthcare implications, treatment options, and ICD-10 codes relevant to this condition. Improve your understanding of this complex interplay of diabetes and gastroparesis for optimal patient care and accurate medical recordkeeping.
Also known as
Diabetes mellitus
Covers various types of diabetes mellitus, including complications.
Diseases of stomach and duodenum
Includes other specified diseases of stomach and duodenum.
Symptoms and signs involving the digestive system and abdomen
Includes symptoms like nausea, vomiting, and abdominal pain.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the gastroparesis confirmed to be caused by diabetes?
Yes
Type of diabetes?
No
Code K31.84 (Gastroparesis, unspecified) and code the underlying diabetes separately if documented.
When to use each related code
| Description |
|---|
| Diabetes with delayed stomach emptying |
| Delayed stomach emptying without diabetes |
| Diabetes without gastroparesis |
Coding requires specific diabetes type (Type 1, Type 2) for accurate reimbursement and clinical documentation.
Documenting gastroparesis severity (mild, moderate, severe) impacts code selection and care management.
Explicitly linking gastroparesis to diabetes is crucial for proper coding and avoids unspecified dyspepsia codes.
Q: How can I differentiate between diabetic gastroparesis and other causes of delayed gastric emptying in patients with diabetes mellitus?
A: Differentiating diabetic gastroparesis from other causes of delayed gastric emptying requires a thorough clinical evaluation. First, confirm the presence of diabetes mellitus and assess for symptoms like postprandial fullness, nausea, vomiting, and early satiety. Then, exclude other potential causes such as mechanical obstruction through upper endoscopy or imaging studies. Consider evaluating medication lists as certain drugs (e.g., anticholinergics, opioids) can mimic gastroparesis. Gastric emptying studies are the gold standard for confirming delayed gastric emptying, but interpret results in the clinical context. For example, a patient with diabetes might have other contributing factors to their symptoms, even if the gastric emptying study result is normal. Explore how a multidisciplinary approach, involving gastroenterologists, endocrinologists, and dietitians, can facilitate accurate diagnosis and personalized management for patients experiencing delayed gastric emptying in the context of diabetes.
Q: What are the best evidence-based management strategies for diabetic gastroparesis, including pharmacological and non-pharmacological approaches?
A: Managing diabetic gastroparesis requires a multifaceted approach addressing both glycemic control and gastric emptying. Optimize blood glucose levels through appropriate diabetes management strategies, as uncontrolled diabetes can exacerbate gastroparesis. Non-pharmacological therapies like dietary modifications (e.g., small, frequent meals, low-fat and low-fiber diets) and behavioral therapies are crucial. Pharmacological options include prokinetics like metoclopramide and erythromycin, which can stimulate gastric motility, and antiemetics to manage nausea and vomiting. Consider implementing a stepped approach, starting with lifestyle modifications and then adding medications based on symptom severity and response. In refractory cases, explore alternative options like gastric electrical stimulation. Learn more about the latest guidelines for diabetic gastroparesis management to stay up-to-date on best practices.
Patient presents with symptoms suggestive of diabetic gastroparesis, a complication of diabetes mellitus. The patient reports experiencing early satiety, postprandial fullness, nausea, vomiting, bloating, and abdominal pain. These symptoms are consistent with delayed gastric emptying, a hallmark of gastroparesis. The patient's medical history is significant for long-standing type 2 diabetes mellitus, which is a known risk factor for developing this condition. Blood glucose levels were reviewed and found to be suboptimally controlled, contributing to the development of autonomic neuropathy, a potential underlying mechanism for gastroparesis. A physical examination revealed no significant abdominal distension or tenderness. Given the patient's history of diabetes and presenting symptoms, a gastric emptying study is recommended to confirm the diagnosis of gastroparesis. Differential diagnoses include functional dyspepsia and peptic ulcer disease. Initial management will focus on optimizing glycemic control through medication adjustments and dietary counseling. Furthermore, prokinetic agents, such as metoclopramide or domperidone, may be considered to improve gastric motility. Patient education regarding dietary modifications, including smaller, more frequent meals and avoiding high-fat foods, will be provided. The patient will be closely monitored for symptom improvement and treatment efficacy. ICD-10 code E11.45 (Type 2 diabetes mellitus with gastroparesis) and CPT codes for gastric emptying study (e.g., 74240) and follow-up visits will be used for billing and coding purposes. Further evaluation and treatment will be based on the results of the gastric emptying study and the patient's response to initial interventions.